Sonoma Pharmaceuticals, Inc. (36) | License Agreements (3)
Recent Contracts
-
Exclusive License and Distribution Agreement between Sonoma Pharmaceuticals, Inc. and Anlicare International dated January 18, 2022
(Filed With SEC on January 20, 2022)
-
Exclusive License and Distribution Agreement between the Company and Dyamed Biotech Pte, Ltd., dated November 4, 2021
(Filed With SEC on November 9, 2021)
-
License, Distribution and Supply Agreement by and between Sonoma Pharmaceuticals, Inc. and Brill International, S.L. dated May 19, 2020
(Filed With SEC on May 26, 2020)